Perioperative medication management Flashcards

1
Q

:) How does aspirin work & what are the implications preoperatively?

A

irreversibly inhibits plt COX so may increase periop blood loss & haemorrhagic complications but may help prevent periop thromboembolic complications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

:) What’s the risk of pre-op aspirin withdrawal in CABG patients? what type of studies this from?

A

increased in-hospital mortality, observational studies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

:) What does POISE-2 tell us about periop aspirin & non cardiac surgery? What are the clinical implications of this? What is an issue with pt exclusion for this trial?

A

aspirin increases bleeding risk but doesn’t improve CV or mortality outcomes, sub-study showed no benefit at reducing AKI risk & no benefit for VTE prevention (but 2/3 of the pts also received VTE prophylaxis & there were low overall VTE rates).
Withold aspirin 7/7 in pts taking it for primary or secondary prevention prior to non-cardiac surgery (however if secondary prevention, discussion btwn cardiologist, neurologist, surgeon & pt) & recommence postop once surgical bleeding risk passed EXCEPT pts undergoing CABG, CEA, popliteal artery aneurysm repair or those who are 6/12 after a BMS or DES or those who are having cataract surgery/minor dental/dermatologic procedures.
Many neurosurgical, where bleeding may be highest risk of severe adverse outcomes, were not enrolled in POISE-2, so optimal strategy for periop aspirin for these pts unknown.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

:) What’s the benefit of aspirin for CABG? does dose matter? what can be given to attenuate risk?

A

A systematic review from the Antiplatelet trialist’s collaboration showed that anti-platelets (esp if given early) are associated with improved graft patency @ an average of 1 year after CABG, similar benefit with low- vs high-dose aspirin. Antacids & PPIs often given preoperatively to attenuate risk.

ACC/AHA 2021: If patients are already taking aspirin, continue up until the time of surgery to reduce ischaemic events (*unless redo OT or bleeding dyscrasias or other risks of sig bleeding). If pt is undergoing elective CABG but not already on aspirin, don’t initiate it <24hrs pre-op (no benefit).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

+ What does the ATACAS trial tell us about prep aspirin 1-2 hours prior to CABG (in pts who had newly commenced aspirin or who hadn’t been on it for at least 5 days pre-op)

A

no difference in death/nonfatal MI/stroke/PE/renal failure or bowel infarct, major haemorrhage & no difference in cardiac tamponade. No sig difference in death or severe disability at 1 year.

Issues included short follow-up (phone call 30 days), half the pts receiving aspirin also had TxA, a large number of pts were eligible but not enrolled, stopped early due to higher event rates than anticipated but the composite end-point included biomarker elevation only- not equivalent in weight against other outcomes

ACC/AHA 2021: further trial showed that if aspirin initiated the night before surgery, incr major bleeding & transfusion rates but no difference in early or late MACE cf placebo.

Therefore, DON’T initiate aspirin for the first time <24hrs prior to CABG.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

:) What are the benefits of aspirin after CABG?

A

mortality benefit

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

:) How should aspirin be managed perioperatively for CABG?

A

if already on it, continue pre-op including day of surgery unless v high bleeding risk. Recommence it 6hrs after surg or extubation (whichever first). The deleterious effects of aspirin on post-op bleeding & transfusion requirement can be attenuated by antifibrinolytic therapy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

:) How should aspirin be managed preoperatively for CEA patients? why? does dose matter?

A

should be started prior to CEA & continued indefinitely, unless contraindications, in both symptomatic & asymptomatic CEA due to reduced stroke risk. Low-dose (81-325mg) aspirin is more effective than high-dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

:) How should aspirin be managed for pts undergoing peripheral artery surgery (including large artery aneurysms)? What is the timing & dosing pre- & postoperative for popliteal artery aneurysms?

A

All pts should have it (commence if not already on it) as it reduces risk of early stent-graft thrombosis following endovascular repair of popliteal artery aneurysms. For repair popliteal artery aneurysms, should start at least 48hrs before the procedure (325-650mg), if within 48hrs give 650mg loading (unless contraindication). Should have postop DAPT for at least 4/52 if bleeding risk low.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

:) How long should pts be on DAPT after DES or BMS?

A

for ACS, at least 12/12 but may consider discontinuation of aspirin after 1-3 months & discontinuation of P2Y12 @ 6/12 could be considered if high risk bleeding. For SIHD: BMS at least 1/12 DAPT. DES at least 6/12 DAPT but 1-3 months could discontinue aspirin & at 3/12 if high bleeding risk may discontinue P2Y12.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

:) What are some surgeries where the risk of major bleeding may outweigh risk of stent thrombosis if urgent surg required within 4-6/52 of BMS or DES placement?

A

neurosurgery, posterior eye or prostatic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

:) For how many days is clopidogrel generally stopped before surgery?

A

5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

:) For how many days is prasugrel generally stopped before surgery?

A

7

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

:) For how many days is ticagrelor stopped before surgery?

A

3-5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

:) What is a systems consideration for pts within 6/12 of BMS or DES insertion requiring an antiplatelet to be ceased for non-cardiac surgery?

A

Perform the surgery @ a centre with 24-hour interventional cardiology coverage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

:) For how many days do pts require DAPT after balloon angioplasty without stenting? How common is this?

A

14 days. <5% of PCIs are performed in this manner.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

:) For how many days after balloon angioplasty should urgent surgery ideally be deferred (if can’t wait 14 days)?

A

48hrs, to confirm stable PCI result

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

:) Does using aspirin impact on the placement of neuraxial block?

A

No, but consider impact if combined with other meds impacting coagulation eg. NSAIDs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

:) How long should clopidogrel be withheld prior to placing a neuraxial block?

A

5-7 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

:) What are the 3 types of acute coronary syndromes?

A

STEMI, NSTEMI & unstable or crescendo angina

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

:) What is the approach to a patient who requires urgent or emergency surgery but who has known or suspected coronary artery disease (or ACS!), heart failure or severe valvular heart disease?

A

urgent cardiology consult for suggestions re: monitoring & medication management (& rarely additional cardiovascular testing)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

+2021 ACC/AHA coronary revascularisation guidelines:
What are some situations where myocardial revascularisation BEFORE non cardiac surgery may improve perioperative outcomes?

What is the cornerstone of therapy for prevention of thrombotic complications with PCI?

What is clopidogrel?

For pts undergiong urgent CABG, for how long should clopidogrel & ticagrelor be discontinued? and elective?

and CABG?

For how long should DAPT be continued after PCI?

If a pt has AF & undergoas PCI, what should happen with their anticoagulants?

A

-pts with significant CAD undergiong high-risk surgery have incr incidence periop CV events but routine prophylactic revascularisation does not reduce risk of death or CV events. Studies excluded pts with high-risk anatomy (unprotected L) main, multivessel CAD, solid organ transplant); for such pts, heart team approach for risk:benefit analysis.

If pts are symptomatic with other clinical indications for revascularisation, consider in accordance with recommendations but not solely to reduce periop complications.

-consider if: unstable CAD (ACS) who are candidates for emerg or urgent revasc, significant L) main disease, pts with high-risk features on noninvasive testing (eg. reversible large anterior wall defect, extensive stress-induced wall motion abnormalities).
Downsides to re-vascularisation are the durations of recovery from CABG or duration of DAPT required prior to proceeding with non-cardiac surgery.
Evidence not robust & suggests pts w stable CAD don’t benefit from prophylactic revascularisation before non-cardiac surgery.

DAPT with aspirin & an oral P2Y12 inhibitor (clopidogrel, ticagrelor or prasugrel)

a prodrug with an active thiol metabolite (CYP2C19>CYP2C9) which irreversibly blocks P2Y12 platelet ADP receptor, reducing platelet aggregation

Genetic polymorphisms may –> poor metabolism of prodrug & inadequate effect, increasing CV risk

The half-life of the parent drug is 6 hours, half-life of active thiol metabolite 30mins

The effect on platelets is irreversible, lasting the lifetime of the platelet (7-10 days); platelet aggregation/bleeding time returns to baseline after 5 days.

Compared to the other P2Y12 inhibitors, clopidogrel is the least potent, requiring longer time to plt (-) after a loading dose. Therefore, the more potent ticagrelor or prasugrel (or clopidogrel) should be used for PCI in ACS. For pts with SIHD undergoing PCI, prasugrel & ticagrelor haven’t been studied for long-term clinical outcomes so use aspirin & clopidogrel. Also, for pts who are undergoing PCI immediately after anti-fibrinolytics, use clopidogrel (others not studied). ?older pts having ACS w PCI clopidogrel may be better than potent ones (lower bleeding risk). Prasugrel is contraindicated in pts w previous TIA or CVA, caution advised in pts <60kg or age >=75kg.

24hrs to reduce major bleeding complications (ACC/AHA 2021) (CABG <5 days after discontinuation of clopidogrel ass’d w major bleeding risks- tamponade or re-operation)
Elective: clopidogrel 5 days, ticagrelor 3 days, prasugrel 7 days (reduce major bleed, product transfusion).

For SELECT patients undergoing PCI, shorter-duration DAPT (1-3 months) is reasonable, with subsequent transition to P2Y12 inhibitor monotherapy to reduce risk of bleeding events, without significant difference in MACE (but these trials were not powered to assess differences in stent thrombosis).

After DES for stable IHD, should have at least 6/12 aspirin + clopidogrel BUT may discontinue aspirin & continue clopidogrel monotherapy after 1-3 months. After 3 months if the patient has high risk of bleeding on DAPT, may discontinue P2Y12 (-).
After 6/12 if no high risk bleeding, may continue DAPT up to max 12/12.

After BMS for stable IHD, should have at least 1 month of aspirin + clopidogrel. if no high risk bleeding, may continue DAPT >1 month, up to max 12/12.

After PCI for ACS, @ least 12/12 aspirin + a P2Y12 (-); it may be reasonable to continue for >1yr if no significant bleeding risk, but may consider discontinuation of aspirin @ 1-3 months & proceed with P2Y12(-) monotherapy. If high risk of overt bleeding, discontinuation of P2Y12(-) @ 6/12 may be reasonable.

After CABG, lifelong aspirin. in selected pts, DAPT w aspirin & ticagrelor or clopidogrel for 1 year may be reasonable (different pathophys; to prevent vein graft occlusion).

If a pt with AF on an oral anticoagulant undergoes PCI, discontinue aspirin after 1-4 weeks & maintain P2Y12 inhibitor along with NOAC or warfarin. NOAC may have lowerste bleeding risk than warfarin.

Rates of stent thrombosis with modern DES is similar or lower than BMS; BMS are rarely used, may be considered if: the patient won’t be able to take DAPT for at least 30 days or high risk of bleeding.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

:) Should pts undergoing cataract surgery have aspirin withheld?

A

no since the risks associated with either continuing or discontinuing aspirin are very small

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

:) What’s dipyridamole & what’s the half-life of it’s MR preparation? Evidence for periop cessation? if decide to, how long?

A

Has vasodilator (phosphodiesterase and adenosine deaminase inhibitor) & anti-platelet activity, usually used after CVA or TIA, 10 hrs.
No data on safety of continuing dipyridamole perioperatively, consider balance of bleeding & ischemic events, withheld 2 days if decide to- if combo aspirin & dipyridamole, withheld 7-10 days prep.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

:) What’s cilostazol & what’s it’s half-life? How long stop preop?

A

Selective PDE-3 enzyme inhibitor, weaker reversible anti platelet activity than P2Y12 receptor blockers. Used for claudication symptoms. 21hrs. Should stop for at least 3 days (manufacturer says at least 5 days). Claudication symptoms may recur then cease again once the medication recommenced.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

:) How do COX-1 (nonselective) & COX-2 selective NSAIDs impact platelets? How long should they be held prior to surgery?

A

COX-1 inhibitors reduce levels of TxA2 hence reduce platelet aggregation. COX-2 inhibitors don’t impact platelets but have negative cardiovascular effects.
Should withhold NSAIDs at least 3/7 before surgery (platelet function does normalise within 24hrs of ibuprofen, after holding most other NSAIDs platelet function normalises within 3 days).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

:) What is bridging anticoagulation & it’s purpose?

A

The administration of a short-acting anticoagulant, typically LMWH, during the interruption of a longer-acting agent, to minimise the time the patient isn’t anticoagulant, minimising their risk of peri-operative thromboembolism.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

:) In which patients is bridging required?

A
  1. Those taking warfarin with a mechanical mitral valve or a mechanical aortic valve with additional stroke risk factors.
  2. Embolic stroke within the previous 3/12 or very high stroke risk (CHADS2-vasc score 7-9)
  3. VTE within the previous 3/12 (since diagnosis- except if calf DVT with no evidence of calf DVT on repeat US)
  4. Selected pts who have had recent coronary stenting
  5. Previous thromboembolism during interruption of chronic anticoagulation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

:) What are the elements of the CHA2DS2-Vasc score?

A

CHF (1)
HTN (1)
Age >=75 (2)
DM (1)
prior TIA/CVA/thromboembolism (2)
Vascular disease (peripheral artery disease, MI, aortic plaque) (1)
female sex (1)
age 65-74 (1)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

:) What are the 3 major risk factors for thromboembolism?

A
  1. AF (if CHA2DS2-Vasc 7-9 or if TIA/stroke within 3/12 or if rheumatic valvular heart disease)
  2. Prosthetic heart valves (mechanical MVR or AVR with additional risk factors (LVEF <=30%, hypercoaguable (infection or cancer surgery), AF, previous thromboembolism) or if stroke or TIA within 6/12)
  3. recent (within 3/12) venous or arterial thromboembolism or VTE with severe thrombophilia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

:) Has the CHA2DS2-Vasc score been prospectively validated in the perioperative setting?

A

No

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

:) What dose of vitamin K, given the day before surgery if the INR is >1.5, should reduce the INR to 1.4 on day of surgery? how long via K take (orally vs IV) to work?

A

1-2.5mg PO
oral 6-10hrs, IV 1-2hrs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

:) Why should patients with mechanical valves NOT routinely have high-dose vitamin K given before invasive procedures?

A

those with mechanical valves since this will delay & reduce the effects of re-anticoagulation with a vitamin K antagonist after the procedure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

:) For how long after mitral valve replacement or repair should elective non-cardiac surgery be delayed, where possible?

A

3 months, since the risk of thromboembolism is highest within that timeframe

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

:) For how long is VKA therapy generally recommended after placement of bioprostetic MVR or AVR?

A

3/12 (INR goal 2.5)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

:) How to approach a patient with mechanical valve on a VKA having dental extraction, minor derm surgery or anterior eye surgery (minor procedures in which bleeding easily controlled) or PPM/ICD insertion?

A

can generally continue the VKA for procedure as long as INR not supra therapeutic (based on 2014 AHA/ACC valve guidelines)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

:) How to approach a pt at low thromboembolic risk who’s on a VKA?

A

withhold warfarin 3-5 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

:) What is the anticoagulant regimen for pts with TAVR (bioprosthetic)?

A

aspirin & clopidogrel for 6/12

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

:) Which patients with mechanical valves require bridging with UFH or SC LMWH?

A

Those with mechanical MVR or TVR, mechanical AVR with risk factors or an older generation mechanical AV (such pts will be on warfarin with INR goal 3 & long-term daily aspirin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

:) What are some additional thromboembolic risk factors which would prompt requirement for bridging in a pt with mechanical AVR requiring surgery where INR must be <1.5?

A

> 1 valve, LVEF <30, AF, previous thromboembolism, hypercoaguable condition (eg. cancer surgery or infection), older generation mechanical valve

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

:) How to bridge?

A

Admit the pt (safety of bridging at home hasn’t been established). Cease warfarin 5 days before procedure & commence IV UFH or LMWH, generally 3 days before procedure, when the INR falls below therapeutic range (aim <1.5 for OT).
discontinue LMWH 24hrs before procedure; if BD LMWH is given, omit the evening dose night before. if once-daily, give half the dose the morning of the day before. This is based on biologic half-life of LMWHs of 3-5hrs, the fact that some residual anticoagulant effect of therapeutic LMWH may be present at 24hrs.
discontinue UFH 4-5hrs before procedure (biologic half-life 45mins)
Recommence heparin asap after surgery & continue it until INR in goal therapeutic range for 2 consecutive days.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

:) Pros & cons of LMWH vs UFH?

A

more convenient, may result in more predictable anticoagulation but cannot reverse as rapidly/reliable if severe bleeding occurs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

:) Should aspirin be continued during bridging?

A

Yes, unless risk major bleeding (neurosurgeon, prostate, posterior eye) in which case withhold aspirin 5/7 prep

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

:) What doses of LMWH given during bridging? or UFH?

A

1mg/kg LMWH 12-hourly, 18 units/kg/hr UFH adjusted to APTT 1.5-2x control

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

:) How long stop bridging LMWH or UFH prior to surg?

A

LMWH 24hrs pre procedure, UFH 4-6 hrs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

:) What agent should be used to emergently reverse VKA in pt w mechanical valve?

A

4-factor PCC or FFP with low-dose oral vitamin K- vit K has slower onset but longer half-life than PCC or FFP so slower to get therapeutic VKA postop if use high-dose vit K

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

:) How to manage a pt within 3/12 of a VTE?

A

delay surgery if possible until 3/12 have passed- no clear evidence for when thromboembolic risk declined to baseline. If Emerg surgery, bridging anticoagulation may be used.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

:) What’s the risk of recurrent early VTE if not anticoagulated? how about if receive warfarin therapy

A

50%, declines to 5% after 3/12 warfarin therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

:) What’s the risk of recurrent arterial embolism from any cardiac source in the first month after an event?

A

0.5% per day

50
Q

:) Definition of & examples of high bleeding risk surgery?

A

2-4% 2-day risk of major bleed (major bleed= fatal, involves critical anatomic site (intracranial, pericardial), requires surgery to correct, Hb drop >=20, transfusion >= 2 units rbc)
procedure >45 mins, AAA repair, CABG, foot/hand/shoulder, laminectomy, neurosurgery, breast Ca, polypectomy, TURP, vascular & gen surg

51
Q

:) Definition of & examples of low bleeding risk?

A

0-2% 2-day risk major bleed
abdo hernia repair, abdo hysterectomy, arthroscopic surgery lasting <45 mins, axillary node dissection, bronchoscopy with or without biopsy, cholecystectomy, GI endoscopy +/- biopsy, thoracocentesis, tooth extraction

52
Q

:) What are the fasting guidelines?

A

adults can have limited solid food up to 6hrs & clear fluids up to 2hrs preop.
infants <6/12 can have formula up to 4hrs, breastmilk up to 3hrs & clear fluid (no >3mL/kg/hr) up to 1hr before OT.
Children >6/12 can have breastmilk or formula up to 6hrs & clear fluids (no >3mL/kg/hr) up to 1hr before anaesthesia.

53
Q

:) What’s the glucocorticoid:mineralocorticoid potency of dexamethasone? pred? hydrocortisone? dex’s anti-inflammatory potency compared with prednisolone or hydrocortisone?

A

25:0
4:0.8
1:1

dexamethasone is 25x more potent than hydrocortisone & 6x more potent than pred, so 0.75mg dex is equivalent to 20mg hydrocortisone equivalent to 5mg pred
6x pred, 25x hydrocortisone

54
Q

:) what’s the dose of rivaroxaban for nonvalvular AF (to prevent stroke & systemic embolism)?
peripheral artery disease (stable) or CAD for prevention of MACE?
venous thromboembolism?

A

-20mg once daily with the evening meal (15mg if CrCl 30-40L/min)
-2.5mg BD (in combination with daily low dose aspirin) for prevent major CV events in CAD or PAD
-10mg BD for VTE prophylaxis hip or knee OT
-15mg BD for 21 days followed by 20mg once daily- if provoked VTE, duration of therapy is 3/12 (providing provoking factor no longer present), if unprovoked, >=3/12 depending on risk of VTE recurrence and bleeding risks. For prophylaxis against VTE recurrence for pts at elevated risk of recurrent VTE following >=6/12 therapeutic anticoagulation, a reduced-intensity regimen of 10mg daily.
-reduce dose in renal impairment, avoid if CrCl <30mL/min

55
Q

:) For how long should rivaroxaban be withheld prior to neuraxial?

A

72hrs

56
Q

:) When can emergency surgery be performed when a patient is on dabigatran?

A

whenever needed if life-threatening, however ideally 1-2 elimination half-lives 13-24hrs

57
Q

:) Which DOAC can be removed by haemodialysis? what’s this handy for?

A

dabigatran
if pt on haemodialysis, they can have it prior to transplant to remove approx 60% plasma [] dabigatran in 2-3hrs, rebound effect can occur as dabigatran highly lipophilic, can redistribute from esxtravasc to intravasc space a few hours after hemodialysis so repeat haemodialysis sessions may be useful in the immediate post-transplant setting.

58
Q

:) What’s a risk stratification tool for VTE?

A

Caprini score (considers pt & surgical factors)

59
Q

:) Whats the dosage for VTE prophylaxis?

A

enoxaparin 0.5mg/kg BD or UFH 5000IU BD, subcut

60
Q

:) What are particular high risk factors (pt) for VTE?

A

stroke <1 month, acute spinal cord injury <1 month, multi-trauma, hip/pelvis/limb fracture

61
Q

:) What are moderate risk factors for VTE?

A

past Hx of VTE
FHx of VTE
coagulopathy (FVL, PT20210A mutation, lupus anticoagulant, anticardiolipin ab, homocystienaemia, HIT (left untreated, heparin-induced thrombocytopaenia= 5-10% daily risk VTE), other congenital or acquired thrombophilia)

62
Q

:) What are some low risk factors for VTE?

A

malignancy
confined to bed
immobile in plaster cast
preg/postpartum
obesity
Hx recurrent/unexplained miscarriage
AMI
heart failure
serious lung disease

63
Q

:) What’s dabigatran?

A

An oral anticoagulant, a prodrug, potent, competitive & reversible direct thrombin (IIa) inhibitor

64
Q

:) What are some advantages/disadvantages of dabigatran vs warfarin?

A

-No need for monitoring (eg. INR with warfarin) BUT since can’t monitor (dilute thrombin clotting time not widely available), difficult to know if therapeutic level achieved

-Like warfarin it can be reversed- but idarucizumab expensive, relatively difficult to access, coagulation risks. CAN be removed by haemodialysis but since so lipophilic, may get a rebound dabigatran effect as moves from fat.

-Relatively predictable pharmacokinetics provided renal function normal (cf warfarin which is influenced by vit K levels, liver function (dabigatran doesn’t use the CYP450 enzyme pathway for elimination), warfarin has variable time to full effect & highly variable elimination half-time of 20-60hrs (mean 40) with clearance of warfarin & synthesis of new CFs required for offset)- dabigatran kinetics heavily influenced by renal clearance, it has prolonged duration of action in renal dysfunction (T1/2B delayed to 28hrs in severe renal impairment vs 12-17hrs with normal renal function)
-rapid onset after PO administration so can get full anticoagulation in short time- bridging usually not required (easier to manage postop anticoagulation cf warfarin for minor/low bleeding risk surgery).

-No risk thrombosis on commencement (unlike warfarin which has initial hyper coagulability due to inhibition of anticoagulant proteins C & S initially as the half-lives of the pro-coagulant factors in circulation pass- in high-risk pts require cross-bridging with enoxaparin while INR becoming therapeutic) & has relatively rapid onset (useful for postop re-establishment of anticoagulation)

-warfarin only once daily dosing (dabigatran BD therapeutic, daily prophylactic for Rx of VTE/PE)- despite warfarin having the disadvantage of INR monitoring

-evidence: dabigatran superior to warfarin for stroke prevention in non-valvular AF, lower overall bleeding but dabigatran higher rates GI bleeding.

65
Q

:) What CHA2DS2-Vasc score moves from high to moderate risk?

A

<7

66
Q

:) For how long should dabigatran be held prior to high bleeding risk surgery?
Neuraxial?

A

at least 48hrs if normal renal function (48-72hrs if CrCl >50mL/min), 96hrs if CrCl 30-49mL/min

Neuraxial:
72hrs if CrCl >80mL/min & no additional risk factors (eg. age >65yo, HTN, concomitant antiplatelets)
96hrs if CrCl 50-79mL/min
120hrs if CrCl 30-49mL/min
no neuraxial if CrCl <30mL/min

67
Q

:) How long before high bleeding risk surgery is heparin infusion ceased?

A

4hrs

68
Q

:) Why are DOACS often preferred to warfarin?

A

lower risk of bleeding
stable pharmacokinetics
ease of use for pts & prescribers

69
Q

:) How is thrombin produced & how does it act?

A

From cleaving prothrombin
Promotes clot formation through activating factors V, VII, XI & catalysing the conversion of fibrinogen to fibrin & by stimulating platelet activation
Insufficient thrombin activity promotes bleeding, excess thrombin activity promotes thrombosis

70
Q

:) While dabigatran has relatively few drug reactions unlike warfarin & doesn’t use the CYP450 enzyme pathway for elimination, what are some potential interactions?

A

Dabigatran levels may be increased by P-gp inhibitors (amiodarone, clarithromycin, verapamil)

71
Q

:) why is dabigatran formulated as a prodrug in a non-crushable capsule?

A

poor POBA (3-7%)

72
Q

:) Does dabigatran have active metabolites?

A

Yes, 4

73
Q

:) How is dabigatran cleared?

A

predominantly renal

74
Q

:) For which patients does dabigatran require dose adjustment?

A

elderly, renal impairment, not hepatic impairment

75
Q

:) What’s factor Xa essential for?

A

generating thrombin from prothrombin (via prothrombinase)

76
Q

:) How do apixaban & rivaroxaban work?

A

direct inhibitors of free & clot-bound factor Xa

77
Q

:) What does thrombin do?

A

Converts fibrinogen to fibrin

78
Q

:) What’s the PO bioavailability of apixaban & rivaroxaban like? and their PPB?

A

Good!
Apix 50-60, riva 60% sans food 100% with food
And high PPB
Given as active drug

79
Q

:) How are apixaban & rivaroxaban excreted?

A

renal & faecal, so less likely to accumulate in renal failure cf dabigatran

80
Q

:) What’s the time to peak plasma level for dabigatran, rivaroxaban & apixaban?

A

2hrs, 2-4hrs, 1-4hrs

81
Q

:) what’s dabigatran’s half life? rivaroxaban? apixaban?

A

12-14hrs

rivaroxaban young 5-9hrs, elderly 11-13hrs

apixaban 8-15hrs

82
Q

:) What’s the relative renal excretion of dabigatran cf rivaroxaban & apixaban?

A

80% vs 35% & 27%

83
Q

:) relative PB of the DOACs?

A

dabi 35%
riva >90%
apix 87%

84
Q

:) What are the 3 main indications for DOACs? And the 4th TGA approved indication for which a DOAC doesn’t currently have PBS approval?

A
  1. prevention of stroke in non-valvular AF
  2. VTE prophylaxis after ortho surgery
  3. Rx or prevention of recurrence of VTE/PE (all 3 DOACs useful for VTE Rx & lowering risk of VTE-related death)
  4. Rivaroxaban for prevention of MACE (stroke, MI, CV death) in pts with CAD or PVD
85
Q

:) How does evidence for rivaroxaban compare with warfarin?

A

Rivaroxaban is non-inferior to warfarin in stroke prevention & has lower rates of intracranial & fatal haemorrhage
higher rate of GI bleeding cf warfarin

86
Q

:) How does evidence for apixaban compare with warfarin?

A

Superior to warfarin in stroke prevention
reduced bleeding complications cf other DOACs

87
Q

:) How do DOACs compare with enoxaparin (40mg/day) in VTE prevention after ortho surgery?

A

All 3 DOACs are superior for VTE prevention without incr bleeding complications- rivaroxaban may have slightly higher bleeding rates than the other DOACs

higher pt satisfaction

88
Q

:) What’s the dose of apixaban for prevention of non-valvular AF?
For VTE prophylaxis after hip/knee surg?
Rx/prevention VTE or PE?

A

5mg BD, halve dose if age >=80, wt <=60kg, Cr >=133micromol/L
2.5mg BD
10mg BD for 1 week then 5mg BD (prevention 2.5mg BD after Rx for >=6/12)

89
Q

:) After biprosthetic tricuspid or mitral valves, following initial 3/12 warfarin, what is adequate to use for thromboprophylaxis?

A

low-dose aspirin

90
Q

:) Which standard laboratory test is highly sensitive to dabigatran? Can it be used for dabigatran monitoring?

A

thrombin time
a normal TT (<20s) excludes presence of dabigatran
can’t be used for dabigatran monitoring as very low/clinically insignificant plasma dabigatran produces a very long/unmeasurable TT & aPTT

91
Q

:) Which standard lab test is useful for monitoring rivaroxaban?

A

prothrombin time- normal PT indicates that a clinically significant rivaroxaban effect isn’t likely

92
Q

:) Is anti-Xa activity useful for monitoring apixaban or rivaroxaban?

A

Not recommended for routine monitoring, however anti-Xa activity of <0.1IU/mL calibrated for LMWH excludes an increased risk of bleeding in pts taking these drugs

93
Q

:) Are specific plasma drug assays available for rivaroxaban & apixaban? and can dabigatran levels be monitored? How may this be useful?

A

Yes- although routine monitoring isn’t needed for dose adjustment due to their predictable pharmacokinetics.
Generally, plasma level of 50ng/mL or more is considered therapeutic.

Dabigatran levels can be monitored using the Hemoclot assay

May be useful to monitor during the perioperative period, if the pt has had a major haemorrhage or if there’s been a significant change in renal or hepatic function.
No studies correlate specific plasma drug levels with clinical outcome.

94
Q

:) How do DOACs effect bedside viscoelastic tests?

A

Prolong the CT for EXTEM & INTEM on ROTEM, dose-dependent

94
Q

:) What may be a useful test, albeit qualitative only & not validated for use for clinical outcomes in periop period, that correlates with plasma DOAC presence & may be useful in the emergency setting where rapid detection of the presence of a drug would alter management?

A

urine dipstick (DOASENSE)

95
Q

:) For how long before surgery should a DOAC be withheld?

A

depends on the:
-DOAC
-dose (prophylactic or therapeutic)
-type of surgery (bleeding risk), neuraxial longer withholding
-renal function
-pt age
a minimum of 2-3 half-lives are required for low bleeding risk procedures, 4-5 half-lives if high bleeding risk (longer for dabigatran if renal impairment)

96
Q

:) Is there a role for bridging with DOACS?

A

Yes- if surgery is delayed & a DOAC has been held for >4 days, bridge with LMWH or heparin infusion.
Otherwise, no role for pre-op bridging since the half-life of the drugs & time off Rx is so short.

97
Q

:) What plasma levels are reasonable for safe performance of many types of surgery? how about for high bleeding risk procedures? neuraxial?

A

<50ng/mL
high bleeding risk procedures it’s <30ngm/L for apixaban or rivaroxaban
neuraxial or dabigatran <20ng/mL

ie. if the plasma level is 20-50ng/mL for dabigatran or 30-50ng/mL for rivaroxaban or apixaban, minimal residual effect & can proceed with caution if surgery can’t be delayed 8hrs

98
Q

:) What’s the risk of recurrence of thromboembolic events among patients receiving a DOAC for management of VTE or PE? why is this a concern perioperatively?

A

up to 3%

such pts may require longer time off high-dose DOAC, they should have a bridging plan or consideration of IVC filters or LAA devices if need to stop anticoagulation & bridging difficult

99
Q

:) For how long after the last dose of a DOAC, for Rx of VTE, should neuraxial be avoided? how about after the last dose of a DOAC, with lower doses for prevention of VTE, should neuraxial be avoided? how about for pts on dabigatran with CrCl <30mL/min

A

Minimum 72hrs (plasma level <20ng/mL- ie. almost undetectable) even longer with dabigatran in renal impairment (96hrs if CrCl 50-79mL/min, 120hrs if CrCl 30-49mL/min)

Pts on dabigatran with CrCl <30mL/min shouldn’t undergo neuraxial blockade

100
Q

:) When should a DOAC be recommenced after a neuraxial or after catheter removal?

A

6hrs

101
Q

:) Should DOACs be given with a regional catheter in situ? what if it’s accidentally given?

A

NO
if inadvertent dosing, wait @ least 34hrs for dabigatran, 22 for rivaroxaban & 26hrs for apixaban

102
Q

:) What’s a nonspecific reversal agent for the DOACs? and specific?

A

PCC (prothrombinex) 25-50IU/kg
specific = idarucizumab for dabigatran (available), adnexanet alfa (n/a in Ax)

102
Q

:) For which pts presenting for emergency surgery may the use of activated charcoal be useful to limit DOAC effect?

A

those where the DOAC was ingested within 3 hrs

103
Q

:) What plasma levels of DOAC are considered high enough to warrant reversal?

A

> 50ng/mL

104
Q

:) is haemodialysis useful for rivaroxaban or apixaban?

A

no- only dabigatran

105
Q

:) For urgent surgery where reversal being considered prior to obtaining plasma DOAC levels (and urine dipstick +ve, suggesting likely significant DOAC in the plasma), what factors may be considered when deciding whether to give empirical reversal?

A

time since ingestion (delay of 12-24hrs often reduced plasma levels significantly if normal renal/hepatic function & on low doses)
type of surgery (eg. high bleeding risk/critical site)
renal function

106
Q

:) what’s idarucizumab? what dose for undetectable dabigatran levels? what’s a risk of taking idarucizumab?

A

monoclonal antibody binding to dabigatran with very high affinity (300x > affinity to thrombin)
dose of 5g reduces dabigatran to <20ng/mL within minutes, for 24hrs in most pts
a 2nd dose may be required after 24hrs if postop bleed

in the RE-VERSE-AD trial, 7% of pts had thrombotic complications within the 1st 90 days

107
Q

:) What’s adexanet alfa?

A

specific reversal agent for apixaban & rivaroxaban
recombinant form of modified human factor Xa that binds to the drug but has no active site hence no effect on coagulation
given as a bolus then infusion as short half life (5hrs). Thrombin generation levels return to 96% normal after administration.

107
Q

:) In what proportion of pts, taking DOACS, can major bleeding be controlled with the off-label use of PCC 25-50IU/kg? risks?

A

2/3
thrombotic complications

108
Q

:) Can FFP be given to reverse DOACs?

A

no
[] of clotting factors too low to be effective

109
Q

:) what’s a possible approach to emergency surgery with a pt on DOACs?

A

proceed to OT with caution, Rx with reversal agent if major bleeding occurs (given thrombotic risks).
Consider mechanical compression, blood transfusion, temp Mx, antifibrinolytic & BP control as supportive measures.

110
Q

:) after high bleeding risk surgery, when should DOACs be recommenced?

A

48-72hrs, even longer if haemostasis has been difficult to achieve.
Bridging may be considered in these cases, particularly if high risk of thromboembolism.
when recommencing postop, always consider if there have been acute changes in pts renal function- consider dose reduction until renal function improves.

111
Q

:) When can a DOAC be resumed after removal of a regional catheter?

A

at least 6hrs

112
Q

What does fondaparinaux inhibit?

A

Factor Xa

113
Q

Why may selective COX-2 inhibitors incr risk of MI & stroke?

A

They inhibit endothelial COX-2 derived prostacyclin but not plt COX-1 derived TxA2

114
Q

Why COX-1 inhibition may trigger asthma?

A

Inhibit the COX-pathway allowing activation of leukotriene pathway & release of leukotrienes that induce bronchospasm & nasal obstruction

115
Q

After ceasing aspirin, how long does it take for platelet activity to be restored?

A

Aspirin’s plasma half-life is 20 mins.
Once discontinued it doesn’t impact new plts once formed.
The lifetime of a plt can be up to 10 days but plt activity restored by 10%/day due to turnover
Can have normal haemoostasis with as little as 20% normal plt COX activity

116
Q

What’s heparin-induced thrombocytopenia? Mortality of HIT?

A

Life-threatening complication from exposure to heparin, an autoantibody directed against endogenous platelet factor 4 in complex with heparin.
Type 1 is mild, nadir usually around 100 & plts typically normalise with continued heparin & there’s no thrombosis, heparin can continue
Type II is clinically significant- the autoantibodies to platelet 4 complex to heparin (PF4/heparin antibodies), it activates platelets causing catastrophic arterial & venous thrombosis and thrombocytopenia (HITT). Can get thrombosis, life-threatening limb gangrene, continue until heparin ceased AND a non-heparin anticoagulant initiated.
Untreated, mortality 20%

117
Q

+for CABG LO: what are elements of fast-track/ERAS anaesthesia for CABG?

A

Prevent early postop complications, minimise exposure to opioid-based analgesia, reduce time to extubation, time in ICU & hospital LoS.
-early PO intake
-bundled SSI prevention (IV insulin infusion to maintain BGL <18 but avoid hypoglycaemia, measure periop HbA1c, redose prophylactic antimicrobials if >2 half-lives of the antibioitc or excessive blood loss. advise smoking cessation)
-multimodal nonopioid analgesia (paracetamol, ketamine, dexmed +/- truncal nerve blocks)
-protocolised short-acting anaesthetics (volatile vs sevo maintenance doesn’t impact mortality rate after cardiac surgery
-lung-protective ventilation strategy (TV 6mL/kg predicted body weight)
-targeted-organ perfusion strategies (goal-directed fluid & vasopressor therapy- inconsistent evidence)
-early postop ambulation

118
Q

+ 2021 ACC/AHA recommendations regarding B blockers & amiodarone in CAGBG:

A

if no contraindications, B-blockers or amiodarone pre-CABG reduce incidence of postop AF. Amiodarone also decr incidence of stroke & reduces hospital LoS, only complication occ bradycardia (individualised, risk toxicity & systemic hypoT). Periop B-blockers may also reduce in-hospital & 30-day mortality rates but their role in preventing acute post-op MI, stroke, AKI or ventricular arrhythmia is unknown.
Pharmacogenetic variation may play a role; non-CYP2D6 metabolised agents (atenolol & sotalol) lower incidence of operative death vs CYP2D6-metabolised agents (metoprolol, propranolol, carvedilol, labetalol). Also, impact on pts w reduced LVEF not established.

119
Q

A patient presents for a trans-urethral resection of the prostate (TURP). He had a single drug-
eluting coronary stent for angina pectoris inserted six months ago and is taking clopidogrel
and aspirin. The most appropriate preoperative management of his medications is to

A

stop both